Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Theravance
Theravance
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Investors Business Daily
Sat, 09/16/17 - 12:11 pm
Amgen
Eli Lilly
JNJ
Exelixis
biotech
Theravance
Bavarian Nordic
Agios
Biohaven Pharmaceuticals
Progenics
Mylan, Theravance’s inhaled COPD therapy proves safe in late-stage trial
Drug Delivery Business News
Thu, 07/20/17 - 10:52 am
Mylan
Theravance
COPD
clinical trials
revefenacin
Sunovion slammed by FDA rejection of nebulized LAMA for COPD as rival lines up a competing NDA
Endpoints
Tue, 05/30/17 - 11:21 am
Sunovion
FDA
LAMA
COPD
Theravance
Mylan Labs
Theravance Bio reports 4Q loss
Yahoo/AP
Mon, 02/27/17 - 10:03 pm
Theravance
earnings
Theravance Biopharma: Interpreting The Revefenacin Trial Results
Seeking Alpha
Mon, 10/24/16 - 09:36 am
Theravance
revefenacin
clinical trials
COPD
Theravance Biopharma and Mylan Announce Positive Results from Two Pivotal Phase 3 Studies of Revefenacin (TD-4208) for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Yahoo
Fri, 10/21/16 - 10:03 am
Theravance
Mylan
clinical trials
COPD
revefenacin
Theravance Bio reports 2Q loss
Yahoo/AP
Tue, 08/9/16 - 10:43 am
Theravance
earnings
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders
Yahoo
Wed, 06/8/16 - 09:58 am
Takeda
Theravance
TD-8954
gastrointestinal motility disorders
Theravance Gets FDA Nod on Vibativ
24/7 Wall St
Mon, 05/9/16 - 10:42 am
Theravance
FDA
Vibativ
SAB
antibiotics
Theravance Inc. Stock Was Up 14% in December -- Here's Why
Motley Fool
Sun, 01/10/16 - 03:19 pm
Theravance
GSK
Breo Ellipta
Will Theravance Succeed in Staph and MRSA?
Yahoo/24-7 Wall St
Mon, 10/12/15 - 11:49 am
Theravance
staph infection
MRSA
Vibativ
10 Worst NASDAQ Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:51 pm
Orexigen
Immunomedics
Celldex Therapeutics
Arena Pharmaceuticals
Theravance
Karyopharm
Raptor Pharmaceutical
Verastem
Tetraphase
Xoma
Regulatory Update: GSK and Theravance Announce Intention to File Relvar(R) Ellipta(R) for COPD in Japan
Yahoo
Fri, 09/25/15 - 09:47 am
GSK
Theravance
COPD
Japan
Relvar Ellipta
There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance
Motley Fool
Wed, 09/16/15 - 06:03 pm
GSK
Theravance
COPD
Breo Ellipta
Study finds key GSK-Theravance lung drug didn't extend lives
Yahoo/AP
Wed, 09/9/15 - 10:39 am
GSK
Theravance
Breo Ellipta
3 Promising Biotechs Hobbled By First-Impression Issues
Seeking Alpha
Mon, 08/10/15 - 09:25 pm
Theravance
Isis Pharmaceuticals
Bacterin International Holdings
Theravance reports 1Q loss
Yahoo/AP
Wed, 05/6/15 - 06:55 pm
Theravance
earnings
GlaxoSmithKline And Theravance: The Asthma Approval In Figures
Seeking Alpha
Sun, 05/3/15 - 10:13 am
GSK
Theravance
asthma
FDA
Breo Ellipta
Breo's Watershed Moment Unlikely To Rescue Glaxo
Seeking Alpha
Sat, 05/2/15 - 01:15 pm
Breo Ellipta
GSK
Theravance
FDA
GSK wins asthma nod for blockbuster wannabe Breo
Fierce Pharma
Fri, 05/1/15 - 03:40 pm
GSK
Theravance
asthma
Breo Ellipta
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »